Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

NRG1 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

NRG1 overexpression	Esophageal Squamous Cell Carcinoma	NRG1 overexpression	Esophageal Squamous Cell Carcinoma	AV-203 Sensitive: C3 – Early Trials AV-203 Sensitive : C3	AV-203 Sensitive: C3 – Early Trials AV-203 Sensitive : C3
NRG1 overexpression	Non Small Cell Lung Cancer	NRG1 overexpression	Non Small Cell Lung Cancer	U3-1287 Sensitive: C3 – Early Trials U3-1287 Sensitive : C3	U3-1287 Sensitive: C3 – Early Trials U3-1287 Sensitive : C3
NRG1 overexpression	HER2 Positive Breast Cancer	NRG1 overexpression	HER2 Positive Breast Cancer	trastuzumab + pertuzumab Sensitive: C3 – Early Trials trastuzumab + pertuzumab Sensitive : C3	trastuzumab + pertuzumab Sensitive: C3 – Early Trials trastuzumab + pertuzumab Sensitive : C3
NRG1 overexpression	Head and Neck Cancer	NRG1 overexpression	Head and Neck Cancer	cetuximab Resistant: D – Preclinical cetuximab Resistant : D	cetuximab Resistant: D – Preclinical cetuximab Resistant : D